HK2 and glioblastoma: Glucose metabolism is a hallmark of glioblastoma’s reliance on glycolysis (the “Warburg effect” [16]) and can be significantly shifted by blocking hexokinase 2 (HK2) [17] or glucose transporter 1 (GLUT1) [18].